These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 3258886

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clonal evidence for the induction of NKH1 on activated human thymocytes. Functional changes associated with antigen expression.
    Caligiuri MA, Murray C, Levine H, Longtine JA, Ritz J.
    Eur J Immunol; 1989 Sep; 19(9):1735-9. PubMed ID: 2477257
    [Abstract] [Full Text] [Related]

  • 23. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL, Benike CJ, Phillips JH, Engleman EG.
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [Abstract] [Full Text] [Related]

  • 24. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH.
    J Immunol; 1986 Jun 15; 136(12):4480-6. PubMed ID: 3086432
    [Abstract] [Full Text] [Related]

  • 25. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
    Faure F, Jitsukawa S, Triebel F, Hercend T.
    J Immunol; 1988 Mar 01; 140(5):1372-9. PubMed ID: 2964471
    [Abstract] [Full Text] [Related]

  • 26. Human cytotoxic effector cells: definition and analysis of activity.
    Ortaldo JR.
    Allergol Immunopathol (Madr); 1991 Mar 01; 19(4):145-56. PubMed ID: 1726345
    [Abstract] [Full Text] [Related]

  • 27. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H, Ueno Y, Taga K, Matsuda A, Miyawaki T, Taniguchi N.
    J Immunol; 1985 Oct 01; 135(4):2351-6. PubMed ID: 3928745
    [Abstract] [Full Text] [Related]

  • 28. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H, Isacescu V, Ibayashi Y, Tokuda Y, Golub SH, Fahey JL, Sarna GP.
    J Biol Response Mod; 1990 Feb 01; 9(1):71-80. PubMed ID: 2319261
    [Abstract] [Full Text] [Related]

  • 29. In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
    Whiteside TL, Wang YL, Selker RG, Herberman RB.
    Cancer Res; 1988 Nov 01; 48(21):6069-75. PubMed ID: 2971433
    [Abstract] [Full Text] [Related]

  • 30. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A, Bertoglio J, Quillet A, Marchiol C, Wakasugi H, Mishall Z, Fradelizi D.
    J Immunol; 1986 Apr 01; 136(7):2463-9. PubMed ID: 3005412
    [Abstract] [Full Text] [Related]

  • 31. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM, Zhu HG, Anderer FA.
    Anticancer Res; 1993 Apr 01; 13(4):923-30. PubMed ID: 8352560
    [Abstract] [Full Text] [Related]

  • 32. IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury.
    Aronson FR, Libby P, Brandon EP, Janicka MW, Mier JW.
    J Immunol; 1988 Jul 01; 141(1):158-63. PubMed ID: 3259966
    [Abstract] [Full Text] [Related]

  • 33. Comparative studies of human FcRIII-positive and negative natural killer cells.
    Nagler A, Lanier LL, Cwirla S, Phillips JH.
    J Immunol; 1989 Nov 15; 143(10):3183-91. PubMed ID: 2530273
    [Abstract] [Full Text] [Related]

  • 34. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 35. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J, Saksela E, Lanier LL.
    J Immunol; 1986 Oct 15; 137(8):2428-33. PubMed ID: 3093576
    [Abstract] [Full Text] [Related]

  • 36. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF, Triglia T, Werkmeister JA.
    J Immunol; 1984 Sep 15; 133(3):1656-63. PubMed ID: 6611374
    [Abstract] [Full Text] [Related]

  • 37. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE, Sieverkropp AJ, Potter J, Andrews RG.
    Am J Primatol; 2006 Aug 15; 68(8):753-64. PubMed ID: 16847969
    [Abstract] [Full Text] [Related]

  • 38. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
    Nagler A, Lanier LL, Phillips JH.
    J Immunol; 1988 Oct 01; 141(7):2349-51. PubMed ID: 3262658
    [Abstract] [Full Text] [Related]

  • 39. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Oct 01; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 40. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.
    Cancer Res; 2000 Sep 01; 60(17):4838-44. PubMed ID: 10987295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.